Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-943P is designated as a "RNA, U6 small nuclear 943, pseudogene," meaning it is a non-coding pseudogene related to the U6 small nuclear RNA (snRNA) gene family. The canonical U6 snRNA is an essential component of the spliceosomal machinery, playing a central role in pre-mRNA splicing by forming critical parts of the spliceosome's catalytic core[1][3]. U6 genes are highly conserved and exist in multiple copies throughout vertebrate genomes, including numerous pseudogenes[3]. However, pseudogenes like RNU6-943P typically do not produce functional RNA or protein products. While some RNA pseudogenes can have regulatory impacts—such as acting as microRNA decoys or producing regulatory noncoding RNA[2]—there is no reported evidence that RNU6-943P is functional or implicated as a therapeutic target, disease biomarker, or drug-interacting molecule. Thus, RNU6-943P is best regarded as a typical U6-derived pseudogene, a result of gene duplication or retrotransposition events with no known biological or clinical function[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 943, pseudogene (RNU6-943P).